CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE. Mediterr J Hematol Infect Dis 2013, 5 (1), e2013031. https://doi.org/10.4084/mjhid.2013.031.